Icares Medicus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 11, 2021 at 06:25 pm EDT
Share
ICARES Medicus, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 95.479 million compared to TWD 91.067 million a year ago. Operating income was TWD 20.275 million compared to TWD 17.555 million a year ago. Net income was TWD 8.534 million compared to TWD 6.621 million a year ago. Basic earnings per share from continuing operations was TWD 0.25 compared to TWD 0.2 a year ago. For the half year, sales was TWD 179.436 million compared to TWD 196.158 million a year ago. Operating income was TWD 32.131 million compared to TWD 46.682 million a year ago. Net income was TWD 14.717 million compared to TWD 30.127 million a year ago. Basic earnings per share from continuing operations was TWD 0.44 compared to TWD 0.9 a year ago. Diluted earnings per share from continuing operations was TWD 0.44 compared to TWD 0.89 a year ago.
Icares Medicus Inc is a Taiwan-based company mainly engaged in the authorization of high-end medical material surface treatment technology. The Company is also involved in the sale of surface treatment formulations and provision of customer surface treatment processing services, as well as the research and development, manufacture and sale of artificial lens and its implantation system. The Company's product revenue is mainly divided into three categories. The royalty income comes from the authorization of implantation/invasive high-end medical material surface treatment technology. The technical service income mainly includes implantation/invasive high-end medical surface treatment services, provision of medical coatings and foundry of artificial lens implantation systems. The sales of medical materials mainly include the sales of medical materials surface inspection equipment and other products. The Company distributes its products in domestic and overseas markets.
ICARES MEDICUS, INC. 
